{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T06:59:53Z","timestamp":1791097193793,"version":"4.1.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2003,10,22]],"date-time":"2003-10-22T00:00:00Z","timestamp":1066780800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2004,2]]},"DOI":"10.1038\/sj.npp.1300330","type":"journal-article","created":{"date-parts":[[2003,10,22]],"date-time":"2003-10-22T09:50:41Z","timestamp":1066816241000},"page":"410-416","source":"Crossref","is-referenced-by-count":129,"title":["Differential Involvement of 5-HT1B\/1D and 5-HT6 Receptors in Cognitive and Non-cognitive Symptoms in Alzheimer's Disease"],"prefix":"10.1038","volume":"29","author":[{"given":"M","family":"Garcia-Alloza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W D","family":"Hirst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C P L-H","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Lasheras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P T","family":"Francis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M J","family":"Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2003,10,22]]},"reference":[{"key":"BF1300330_CR1","unstructured":"American Psychiatric Association (1987). Diagnostic and Statistical Manual of Mental Disorders III-R ed. APA: Washington DC."},{"key":"BF1300330_CR2","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0891-0618(01)00099-0","volume":"22","author":"S Bahn","year":"2001","unstructured":"Bahn S, Augood SJ, Ryan M, Standaert DG, Starkey M, Emson PC (2001). Gene expression profiling in the post-mortem human brain\u2014no cause for dismay. J Chem Neuroanat 22: 79\u201394.","journal-title":"J Chem Neuroanat"},{"key":"BF1300330_CR3","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/00001756-199011000-00021","volume":"1","author":"NM Barnes","year":"1990","unstructured":"Barnes NM, Costall B, Naylor RJ, Williams TJ, Wischik CM (1990). Normal densities of 5-HT3 receptor recognition sites in Alzheimer's disease. NeuroReport 1: 253\u2013254.","journal-title":"NeuroReport"},{"key":"BF1300330_CR4","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/S0028-3908(99)00010-6","volume":"38","author":"NM Barnes","year":"1999","unstructured":"Barnes NM, Sharp T (1999). A review of central 5-HT receptors and their function. Neuropharmacology 38: 1083\u20131152.","journal-title":"Neuropharmacology"},{"key":"BF1300330_CR5","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1038\/sj.bjp.0702445","volume":"126","author":"JC Bentley","year":"1999","unstructured":"Bentley JC, Bourson A, Boess FG, Fone KC, Marsden CA, Petit N et al (1999). Investigation of stretching behaviour induced by the selective 5-HT6 receptor antagonist, Ro 04-6790, in rats. Br J Pharmacol 126: 1537\u20131542.","journal-title":"Br J Pharmacol"},{"key":"BF1300330_CR6","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/S0272-7358(97)00039-1","volume":"17","author":"ME Berman","year":"1997","unstructured":"Berman ME (1997). The serotonin hypothesis of aggression revisited. Clin Psychol Rev 17: 651\u2013665.","journal-title":"Clin Psychol Rev"},{"key":"BF1300330_CR7","first-page":"173","volume":"274","author":"A Bourson","year":"1995","unstructured":"Bourson A, Borroni E, Austin RH, Monsma Jr FJ, Sleight AJ (1995). Determination of the role of the 5-ht6 receptor in the rat brain: a study using antisense oligonucleotides. J Pharmacol Exp Ther 274: 173\u2013180.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF1300330_CR8","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford MM (1976). A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248\u2013254.","journal-title":"Anal Biochem"},{"key":"BF1300330_CR9","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1146\/annurev.pharmtox.40.1.319","volume":"40","author":"TA Branchek","year":"2000","unstructured":"Branchek TA, Blackburn TP (2000). 5-ht6 receptors as emerging targets for drug discovery. Ann Rev Pharmacol Toxicol 40: 319\u2013334.","journal-title":"Ann Rev Pharmacol Toxicol"},{"key":"BF1300330_CR10","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S0959-4388(97)80013-X","volume":"7","author":"MC Buhot","year":"1997","unstructured":"Buhot MC (1997). Serotonin receptors in cognitive behaviors. Curr Opin Neurobiol 7: 243\u2013254.","journal-title":"Curr Opin Neurobiol"},{"key":"BF1300330_CR11","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3109\/07853890008998828","volume":"32","author":"MC Buhot","year":"2000","unstructured":"Buhot MC, Martin S, Segu L (2000). Role of serotonin in memory impairment. Ann Med 32: 210\u2013221.","journal-title":"Ann Med"},{"key":"BF1300330_CR12","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/0006-8993(95)01092-0","volume":"704","author":"JC Cassel","year":"1995","unstructured":"Cassel JC, Jeltsch H, Neufang B, Lauth D, Szabo B, Jackisch R (1995). Downregulation of muscarinic and 5-HT1B-mediated modulation of [3H]acetylcholine release in hippocampal grafts of septal origin. Brain Res 704: 153\u2013156.","journal-title":"Brain Res"},{"key":"BF1300330_CR13","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1046\/j.1471-4159.1996.66041592.x","volume":"66","author":"CPLH Chen","year":"1996","unstructured":"Chen CPLH, Alder JT, Bowen DM (1996). Presynaptic serotonergic markers in community-acquired cases of Alzheimer's disease: correlations with depression and neuroleptic medication. J Neurochem 66: 1592\u20131598.","journal-title":"J Neurochem"},{"key":"BF1300330_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1365-2990.2000.00254.x","volume":"26","author":"CPLH Chen","year":"2000","unstructured":"Chen CPLH, Eastwood SL, Hope T, McDonald B, Francis PT, Esiri MM (2000). Immunocytochemical study of the dorsal and median raphe nuclei in patients with Alzheimer's disease prospectively assessed for behavioural changes. Neuropath App Neurobiol 26: 1\u201310.","journal-title":"Neuropath App Neurobiol"},{"key":"BF1300330_CR15","first-page":"467","volume-title":"Research Advances in Alzheimer's Disease and Related Disorders","author":"CHLH Chen","year":"1995","unstructured":"Chen CHLH, Hope R, Alder JT, Eastwood S, Gedling K, McDonald B et al (1995). Loss of paroxetine binding in the neocortex is associated with depression in Alzheimer's disease. In: Iqbal K, Mortimer J, Winbad B, Wisnieski H (eds) Research Advances in Alzheimer's Disease and Related Disorders. John Wiley & Sons Ltd: New York. pp 467\u2013473."},{"key":"BF1300330_CR16","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/0022-510X(91)90193-B","volume":"106","author":"AVT Cheng","year":"1991","unstructured":"Cheng AVT, Ferrier IN, Morris CM, Jabeen S, Sahgal A, McKeith IG et al (1991). Cortical serotonin-S2 receptor binding in Lewy body dementia, Alzheimer's and Parkinson's diseases. J Neurol Sci 106: 50\u201355.","journal-title":"J Neurol Sci"},{"key":"BF1300330_CR17","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/j.1749-6632.1990.tb16897.x","volume":"600","author":"AJ Cross","year":"1990","unstructured":"Cross AJ (1990). Serotonin in Alzheimer-type dementia and other dementing illnesses. Ann N Y Acad Sci 600: 405\u2013415.","journal-title":"Ann N Y Acad Sci"},{"key":"BF1300330_CR18","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1097\/00005072-198407000-00001","volume":"43","author":"CA Curcio","year":"1984","unstructured":"Curcio CA, Kemper T (1984). Nucleus raphe dorsalis in dementia of the Alzheimer type: neurofibrillary changes and neuronal packing density. J Neuropathol Exp Neurol 43: 359\u2013368.","journal-title":"J Neuropathol Exp Neurol"},{"key":"BF1300330_CR19","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1111\/j.1476-5381.1995.tb13321.x","volume":"114","author":"C Davidson","year":"1995","unstructured":"Davidson C, Stanford J (1995). Evidence that 5-hydroxytryptamine release in rat dorsal raphe nucleus is controlled by 5-HT1A, 5-HT1B and 5-HT1D autoreceptors. Br J Pharmacol 114: 1107\u20131109.","journal-title":"Br J Pharmacol"},{"key":"BF1300330_CR20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/sj.bjp.0703288","volume":"130","author":"LA Dawson","year":"2000","unstructured":"Dawson LA, Nguyen HQ, Li P (2000). In vivo effects of the 5HT6 receptor antagonist SB-270146 on striatal and frontal cortex extracellular concentrations of noradrenaline, dopamine, 5-HT, glutamate and aspartate. Br J Pharmacol 130: 23\u201326.","journal-title":"Br J Pharmacol"},{"key":"BF1300330_CR21","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/S0893-133X(01)00265-2","volume":"25","author":"LA Dawson","year":"2001","unstructured":"Dawson LA, Nguyen HQ, Li P (2001). The 5HT6 receptor antagonist SB-270146 selectively enhances excitatory neurotransmission in the rat frontal cortex and hippocampus. Neuropsychopharmacology 25: 662\u2013668.","journal-title":"Neuropsychopharmacology"},{"key":"BF1300330_CR22","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S0361-9230(02)00967-X","volume":"59","author":"L Dawson","year":"2003","unstructured":"Dawson L, Nguyen HQ, Li P (2003). Potentiation of amphetamine-induced changes in dopamine and 5-HT by a 5-HT6 receptor antagonist. Brain Res Bull 59: 513\u2013521.","journal-title":"Brain Res Bull"},{"key":"BF1300330_CR23","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/PL00005058","volume":"356","author":"T Domenech","year":"1997","unstructured":"Domenech T, Beleta J, Palacios JM (1997). Characterization of human serotonin 1D and 1B receptors using [3H]-GR-125743, a novel radiolabelled serotonin 5-HT1D\/1B receptor antagonist. Naunyn-Schmiedderberg's Arch Pharamacol 356: 328\u2013334.","journal-title":"Naunyn-Schmiedderberg's Arch Pharamacol"},{"key":"BF1300330_CR24","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1136\/jnnp.61.2.127","volume":"61","author":"MM Esiri","year":"1996","unstructured":"Esiri MM (1996). The basis for behavioural disturbances in dementia. J Neurol Neurosurg Psychiatry 61: 127\u2013130.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BF1300330_CR25","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein S, McHugh PR (1975). Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189\u2013198.","journal-title":"J Psychiatr Res"},{"key":"BF1300330_CR26","first-page":"238P","volume":"131","author":"CF Fone","year":"2000","unstructured":"Fone CF (2000). The 5-HT6 receptor: potential CNS functions. Br J Pharmacol 131: 238P.","journal-title":"Br J Pharmacol"},{"key":"BF1300330_CR27","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/j.1471-4159.1975.tb11895.x","volume":"24","author":"F Fonnun","year":"1975","unstructured":"Fonnun F (1975). A rapid radiochemical method for the determination of choline acetyltransferase. J Neurochem 24: 407\u2013409.","journal-title":"J Neurochem"},{"key":"BF1300330_CR28","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1192\/bjp.165.1.53","volume":"165","author":"H Forstl","year":"1994","unstructured":"Forstl H, Burns A, Levy R, Cairns N (1994). Neuropathological correlates of psychotic phenomena in confirmed Alzheimer's disease. Br J Psychiatry 165: 53\u201359.","journal-title":"Br J Psychiatry"},{"key":"BF1300330_CR29","unstructured":"Garcia-Alloza M, Gil-Bea FJ, Diez-Ariza M, Chen CPLH, Francis PT, Lasheras B et al Cholinergic-serotonergic imbalance contributes to cognitive and behavioral symptoms in Alzheimer's disease (submitted)."},{"key":"BF1300330_CR30","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0006-8993(96)01224-3","volume":"746","author":"C Gerard","year":"1997","unstructured":"Gerard C, Martres MP, Lefevre K, Miquel MC, Verg\u00e9 D, Lanumey L et al (1997). Inmunolocalization of serotonin 5-HT6 receptor-like material in the rat central nervous system. Brain Res 746: 207\u2013219.","journal-title":"Brain Res"},{"key":"BF1300330_CR31","first-page":"33","volume":"30","author":"CG Gottfries","year":"1990","unstructured":"Gottfries CG (1990). Disturbance of the 5-hydroxytryptamine metabolism in brains from patients with Alzheimer's dementia. J Neural Transm 30: 33\u201343.","journal-title":"J Neural Transm"},{"key":"BF1300330_CR32","first-page":"68S","volume":"21","author":"M Hamon","year":"1999","unstructured":"Hamon M, Doucet E, Lefevre K, Miquel MC, Lanfumey L, Insausti R et al (1999). Antibodies and antisense oligonucleotide for probing the distribution and putative functions of central 5-HT6 receptos. Neuropsychopharmacology 21: 68S\u201376S.","journal-title":"Neuropsychopharmacology"},{"key":"BF1300330_CR33","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1038\/sj.bjp.0703458","volume":"130","author":"WD Hirst","year":"2000","unstructured":"Hirst WD, Minton JAL, Bromidge SM, Moss SF, Latter AJ, Riley G et al (2000). Characterization of [125I]-SB-258585 binding to human recombinant and native 5-HT6 receptors in rat, pig and human brain tissue. Br J Pharmacol 130: 1597\u20131605.","journal-title":"Br J Pharmacol"},{"key":"BF1300330_CR34","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1017\/S0033291700032888","volume":"22","author":"T Hope","year":"1992","unstructured":"Hope T, Fairburn CG (1992). The present behavioural examination (PBE): the development of an interview to measure current behavioural abnormalities. Psychol Med 22: 223\u2013230.","journal-title":"Psychol Med"},{"key":"BF1300330_CR35","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1002\/(SICI)1099-1166(199711)12:11<1062::AID-GPS675>3.0.CO;2-N","volume":"12","author":"T Hope","year":"1997","unstructured":"Hope T, Keene J, Fairburn C, McShane R, Jacoby R (1997). Behavior changes in dementia 1: point of entry data of a prospective study. Int J Geriat Psychiatry 12: 1062\u20131073.","journal-title":"Int J Geriat Psychiatry"},{"key":"BF1300330_CR36","unstructured":"IPA (1996). Behavioral and psychological signs and symptoms in dementia (BPSSD): implications for research and treatment. Int Psychogeriatr 8: 215\u2013552."},{"key":"BF1300330_CR37","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1523\/JNEUROSCI.12-05-02000.1992","volume":"12","author":"SW Johnson","year":"1992","unstructured":"Johnson SW, Mercuri NB, North RA (1992). 5-Hydroxytryptamine1b receptors block the GABAB synaptic potential in rat dopamine neurons. J Neurosci 12: 2000\u20132006.","journal-title":"J Neurosci"},{"key":"BF1300330_CR38","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/S0091-3057(01)00745-6","volume":"71","author":"BJ Jones","year":"2002","unstructured":"Jones BJ, Blackburn TP (2002). The medical benefit of 5-HT research. Pharmacol Biochem Behav 71: 555\u2013568.","journal-title":"Pharmacol Biochem Behav"},{"key":"BF1300330_CR39","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1002\/(SICI)1099-1166(199907)14:7<541::AID-GPS961>3.0.CO;2-P","volume":"14","author":"J Keene","year":"1999","unstructured":"Keene J, Hope T, Fairburn C, Jacoby R, Gedling K, Ware C (1999). The natural history of aggressive behaviour in dementia. Int J Geriat Psychiatry 14: 541\u2013548.","journal-title":"Int J Geriat Psychiatry"},{"key":"BF1300330_CR40","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1212\/WNL.57.5.805","volume":"57","author":"MKP Lai","year":"2001","unstructured":"Lai MKP, Lai OF, Keene J, Esiri MM, Francis PT, Hope T et al (2001). Psychosis of Alzheimer's disease is associated with elevated muscarinic M2 binding in the cortex. Neurology 57: 805\u2013811.","journal-title":"Neurology"},{"key":"BF1300330_CR41","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1097\/00001756-200207020-00021","volume":"13","author":"MKP Lai","year":"2002","unstructured":"Lai MKP, Tsang SWY, Francis PT, Keene J, Hope T, Esiri MM et al (2002). Post-mortem serotonergic correlates of cognitive decline in Alzheimer's disease. NeuroReport 13: 1175\u20131178.","journal-title":"NeuroReport"},{"key":"BF1300330_CR42","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1159\/000052760","volume":"45","author":"ML Levy","year":"1999","unstructured":"Levy ML, Cummings JL, Kahn-Rose R (1999). Neuropsychiatric symptoms and cholinergic therapy for Alzheime's disease. Gerontology 45: 15\u201322.","journal-title":"Gerontology"},{"key":"BF1300330_CR43","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0893-133X(01)00393-1","volume":"26","author":"DA Lewis","year":"2002","unstructured":"Lewis DA (2002). The human brain revisited: opportunities and challenges in post-mortem studies of psychiatric disorders. Neuropsychopharmacology 26: 143\u2013154.","journal-title":"Neuropsychopharmacology"},{"key":"BF1300330_CR44","first-page":"46","volume":"53","author":"VMI Linnoila","year":"1992","unstructured":"Linnoila VMI, Virkkunen M (1992). Aggression, suicidality and serotonin. J Clin Psychiatry 53: 46\u201351.","journal-title":"J Clin Psychiatry"},{"key":"BF1300330_CR45","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1207\/s15327655jchn1201_5","volume":"12","author":"IM Martinson","year":"1995","unstructured":"Martinson IM, Muwaswes J, Gilliss CL, Doyle GD, Zimmerman S (1995). The frequency and troublesomeness of syndromes associated with Alzheimer's disease. J Community Health Nurs 12: 47\u201357.","journal-title":"J Community Health Nurs"},{"key":"BF1300330_CR46","first-page":"333","volume":"129","author":"G Maura","year":"1986","unstructured":"Maura G, Raiteri M (1986). Cholinergic terminals in rat hippocampus posses 5-HT1B receptor mediating inhibition of acetylcholine release. Eur J Neurosci 129: 333\u2013337.","journal-title":"Eur J Neurosci"},{"key":"BF1300330_CR47","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein MF, Katzman R, Price D, Stadlan EM (1984). Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34: 939\u2013944.","journal-title":"Neurology"},{"key":"BF1300330_CR48","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S0893-133X(97)00194-2","volume":"18","author":"CC Meltzer","year":"1998","unstructured":"Meltzer CC, Smith G, DeKosky ST, Pollock BG, Mathis CA, Moore RY et al (1998). Serotonin in aging, late-life depression, and Alzheimer's disease: the emerging role of functional imaging. Neuropsychopharmacology 18: 407\u2013430.","journal-title":"Neuropsychopharmacology"},{"key":"BF1300330_CR49","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0149-7634(01)00007-0","volume":"25","author":"A Meneses","year":"2001","unstructured":"Meneses A (2001). Could 5-HT1B receptor inverse agonism affect learning consolidation? Neurosci Biobehv Rev 25: 193\u2013201.","journal-title":"Neurosci Biobehv Rev"},{"key":"BF1300330_CR50","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0166-4328(96)02266-8","volume":"87","author":"A Meneses","year":"1997","unstructured":"Meneses A, Hong E (1997). Role of 5-HT1B, 5-HT2A and 5-HT2C receptors in learning. Behav Brain Res 87: 105\u2013110.","journal-title":"Behav Brain Res"},{"key":"BF1300330_CR51","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0166-4328(97)00055-7","volume":"89","author":"A Meneses","year":"1997","unstructured":"Meneses A, Terr\u00f3n JA, Hong E (1997). Effects of the 5-HT receptor antagonists GR127935 (5-HT1B\/1D) and MDL100907 (5-HT2A) in the consolidation of learning. Behav Brain Res 89: 217\u2013223.","journal-title":"Behav Brain Res"},{"key":"BF1300330_CR52","first-page":"118","volume":"2","author":"J Miguel-Hidalgo","year":"2001","unstructured":"Miguel-Hidalgo J (2001). SB-271046. Curr Opin Invest Drugs 2: 118\u2013122.","journal-title":"Curr Opin Invest Drugs"},{"key":"BF1300330_CR53","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1212\/WNL.41.4.479","volume":"41","author":"SS Mirra","year":"1991","unstructured":"Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM et al (1991). The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standarization of neuropathologic assessment of Alzheimer's disease. Neurology 41: 479\u2013486.","journal-title":"Neurology"},{"key":"BF1300330_CR54","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/BF00711237","volume":"12","author":"AJ Nazarali","year":"1992","unstructured":"Nazarali AJ, Reynolds GP (1992). Monoamine neurotransmitters and their metabolites in brain regions in Alzheimer's disease: a postmortem study. Cell Mol Neurobiol 12: 581\u2013587.","journal-title":"Cell Mol Neurobiol"},{"key":"BF1300330_CR55","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/S0306-4522(99)00066-4","volume":"92","author":"A Otano","year":"1999","unstructured":"Otano A, Frechilla D, Cobreros A, Cruz-Orive LM, Insausti A, Insausti R et al (1999). Anxiogenic-like effects and reduced stereological counting of immunolaelled 5-hydroxytryptamine6 receptors in rat nucleus accumbens by antisense oligonucleotides. Neuroscience 92: 1001\u20131009.","journal-title":"Neuroscience"},{"key":"BF1300330_CR56","first-page":"286","volume-title":"Brain 5-HT1A Receptors","author":"AM Palmer","year":"1987","unstructured":"Palmer AM, Middlemiss DN, Bowen DM (1987a). [3H]8-OH-DPAT binding in Alzheimer's disease: an index of pyramidal cell loss?. In: Dourish C, Ahlenius A, Hutson P (eds.) Brain 5-HT1A Receptors. Ellis Howood Ltd., Chichester. pp 286\u2013299."},{"key":"BF1300330_CR57","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/0006-8993(87)91408-9","volume":"20","author":"AM Palmer","year":"1987","unstructured":"Palmer AM, Wilcock GK, Esiri MM, Francis PT, Bowen DM (1987b). Monoaminergic innervation of the frontal and temporal lobes in Alzheimer's disease. Brain Res 20: 231\u2013238.","journal-title":"Brain Res"},{"key":"BF1300330_CR58","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1016\/S0047-6374(01)00316-5","volume":"122","author":"L Parnetti","year":"2001","unstructured":"Parnetti L, Amici S, Lanari A, Gallai V (2001). Pharmacological treatment of non-cognitive disturbances in dementia disorders. Mech Ageing Develop 122: 2063\u20132069.","journal-title":"Mech Ageing Develop"},{"key":"BF1300330_CR59","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/0197-4580(92)90113-C","volume":"13","author":"EK Perry","year":"1992","unstructured":"Perry EK, Johnson M, Kerwin JM, Piggot MA, Court JA, Shaw PJ et al (1992). Convergent cholinergic activities in aging and Alzheimer's disease. Neurobiol Aging 13: 393\u2013400.","journal-title":"Neurobiol Aging"},{"key":"BF1300330_CR60","first-page":"273","volume":"22","author":"EK Perry","year":"1999","unstructured":"Perry EK, Walker M, Grace J, Perry R (1999). Acetylcholine in mind: a neurotransmitter correlate of consciousness? TINS 22: 273\u2013280.","journal-title":"TINS"},{"key":"BF1300330_CR61","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1007\/BF00993268","volume":"17","author":"AW Procter","year":"1992","unstructured":"Procter AW, Francis PT, Stratmann GC, Bowen DM (1992). Serotonergic pathology is not widespread in Alzheimer patients without prominent aggresive symptoms. Neurochem Res 17: 917\u2013922.","journal-title":"Neurochem Res"},{"key":"BF1300330_CR62","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/0309-1651(89)90024-6","volume":"13","author":"M Raiteri","year":"1989","unstructured":"Raiteri M, Marchi M, Maura G, Bonanno G (1989). Presynaptic regulation of acetylcholine release in the CNS. Cell Biol Int Rep 13: 1109\u20131118.","journal-title":"Cell Biol Int Rep"},{"key":"BF1300330_CR63","first-page":"104","volume":"2","author":"C Reavill","year":"2001","unstructured":"Reavill C, Rogers DC (2001). The therapeutic potential of 5HT6 receptor antagonists. Curr Opin Invest Drugs 2: 104\u2013109.","journal-title":"Curr Opin Invest Drugs"},{"key":"BF1300330_CR64","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1021\/jm021085c","volume":"46","author":"C Riemer","year":"2003","unstructured":"Riemer C, Borroni E, Levet-Trafit B, Martin JR, Poli S, Porter RHP et al (2003). Influence of the 5-HT6 receptor on acetylcholine release in the cortex: pharmacological characterisation of 4-(2-Bromo-6-pyrrolidin-1-ylpyridine-4-sulfonyl)phenylamine, a potent and selective 5-HT6 receptor antagonist. J Med Chem 46: 1273\u20131276.","journal-title":"J Med Chem"},{"key":"BF1300330_CR65","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s002130100840","volume":"158","author":"DC Rogers","year":"2001","unstructured":"Rogers DC, Hagan JJ (2001). 5-HT6 receptor antagonists enhance retention of a water maze task in the rat. Psychopharmacology 158: 114\u2013119.","journal-title":"Psychopharmacology"},{"key":"BF1300330_CR66","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1192\/bjp.149.6.698","volume":"149","author":"M Roth","year":"1986","unstructured":"Roth M, Tym E, Montjoy CQ, Huppert FA, Hendrie H, Verma S et al (1986). CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry 149: 698\u2013709.","journal-title":"Br J Psychiatry"},{"key":"BF1300330_CR67","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1007\/s002109900067","volume":"360","author":"H Sarham","year":"1999","unstructured":"Sarham H, Fillion G (1999). Differential sensitivity of 5-HT1B auto and heteroreceptors. Naunyn-Schmiedeberg's Arch Pharmacol 360: 382\u2013390.","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"BF1300330_CR68","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/S0165-0173(96)00009-4","volume":"23","author":"M Sarter","year":"1997","unstructured":"Sarter M, Bruno JP (1997). Cognitive functions of cortical acetylcholine: toward a unifying hypothesis. Brain Res Rev 23: 28\u201346.","journal-title":"Brain Res Rev"},{"key":"BF1300330_CR69","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S0893-133X(01)00400-6","volume":"26","author":"S Shirazi-Southall","year":"2002","unstructured":"Shirazi-Southall S, Rodriguez DE, Nomikos GG (2002). Effects of typical and atypical antipsychotics and receptor selective compounds on acetylcholine efflux in the hippocampus of the rat. Neuropsychopharmacology 26: 583\u2013594.","journal-title":"Neuropsychopharmacology"},{"key":"BF1300330_CR70","first-page":"214","volume":"10","author":"AJ Sleight","year":"1997","unstructured":"Sleight AJ, Boess G, Bourson A, Sibley DR, Monsma FJ (1997). 5-HT6 and 5-HT7 serotonin receptors: molecular biology, functional correlates and possible therapeutic indications. Drugs News Perspect 10: 214\u2013224.","journal-title":"Drugs News Perspect"},{"key":"BF1300330_CR71","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1002\/ana.410310608","volume":"31","author":"DL Sparks","year":"1992","unstructured":"Sparks DL, Hunsaker JC, Slevin JT, DeKosky ST, Kryscio RJ, Markesbery WR (1992). Monoaminergic and cholinergic synaptic markers in the nucleus basalis of Meynert (nbM): normal age-related changes and the effect of heart disease and Alzheimer's disease. Ann Neurol 31: 611\u2013620.","journal-title":"Ann Neurol"},{"key":"BF1300330_CR72","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1017\/S1041610200006657","volume":"12","author":"RA Sweet","year":"2000","unstructured":"Sweet RA, Hamilton RL, Lopez OL, Klunk WE, Wisniewski SR, Kaufer DI et al (2000). Psychotic symptoms in Alzheimer's disease are not associated with more severe neuropathologic features. Int Psychogeriatr 12: 547\u2013558.","journal-title":"Int Psychogeriatr"},{"key":"BF1300330_CR73","unstructured":"Tecott LH, Chu HM, Brennan TJ (1998). Neurobehavioral analysis of 5-HT6 receptor null mutant mice. IUPHAR Satellite Meet on Serotonin. Rotterdam (Abstract) S1\u2013S2."},{"key":"BF1300330_CR74","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1002\/(SICI)1096-9861(19960701)370:3<405::AID-CNE10>3.0.CO;2-R","volume":"370","author":"RP Ward","year":"1996","unstructured":"Ward RP, Dorsa DM (1996). Colocalization of serotonin receptor subtypes 5-HT2A, 5-HT2C and 5-HT6 with neuropeptides in rat striatum. J Comp Neurol 370: 405\u2013414.","journal-title":"J Comp Neurol"},{"key":"BF1300330_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0304-3940(02)01339-3","volume":"338","author":"M Wolff","year":"2003","unstructured":"Wolff M, Savova M, Malleret G, Hen R, Segu L, Buhot MC (2003). Serotonin 1B knockout mice exhibit a task-dependent selective learning facilitation. Neurosci Lett 338: 1\u20134.","journal-title":"Neurosci Lett"},{"key":"BF1300330_CR76","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/S0028-3908(01)00056-9","volume":"41","author":"ML Woolley","year":"2001","unstructured":"Woolley ML, Bentley AJ, Sleight AJ, Marsden CA, Fone KCF (2001a). A role for 5-ht6 receptors in retention of spatial learning in the Morris water maze. Neuropharmacology 41: 210\u2013219.","journal-title":"Neuropharmacology"},{"key":"BF1300330_CR77","first-page":"64","volume":"129","author":"ML Woolley","year":"2001","unstructured":"Woolley ML, Marsden CA, Sleight AJ, Fone KCF (2001b). Reversal of a scopolamine-induced deficit in object discrimination by a selective 5-HT6 receptor antagonist, Ro-046790, in rats. Br J Pharmacol 129: 64.","journal-title":"Br J Pharmacol"},{"key":"BF1300330_CR78","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1001\/archneur.1991.00530180075020","volume":"48","author":"GS Zubenko","year":"1991","unstructured":"Zubenko GS, Moossy J, Martinez J, Rao G, Claassen K, Rosen J et al (1991). Neuropathologic and neurochemical correlates of psychosis in primary dementia. Arch Neurol 48: 619\u2013624.","journal-title":"Arch Neurol"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/1300330.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/1300330","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/1300330.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T06:45:18Z","timestamp":1684219518000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1300330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,10,22]]},"references-count":78,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,2]]}},"alternative-id":["BF1300330"],"URL":"https:\/\/doi.org\/10.1038\/sj.npp.1300330","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,10,22]]}}}